Internationally, screening programmes and clinical practice guidelines recommend when older adults should stop cancer screening using upper age limits, but it is unknown how older adults view these recommendations. The obective of this study is to examine older adults’ views and experiences about continuing or [...]
Primary care practitioners (PCPs) play a key role in cancer screening decisions for older adults (≥ 65 years), but recommendations vary by cancer type and jurisdiction. The purpose of this study is to examine the factors influencing PCPs’ recommendations for breast, cervical, prostate, and colorectal cancer [...]
Deciding whether it is worthwhile to advise older adults (aged ≥ 65 years) to continue or stop cancer screening is not straightforward for primary care practitioners (PCPs). At a population level, there is evidence that the benefit/harm trade-off of cancer screening becomes less favorable in older adults. The [...]
To examine the impact of self-reported human papillomavirus (HPV) test result (HPV negative, HPV positive, HPV result unknown) on a range of psychosocial outcomes. Women and other people with a cervix in Australia aged 25–74 years who reported having participated in cervical screening since December [...]
When presented with balanced information on the benefits and harms of different management options for CIN2 and given a choice, most women in this hypothetical situation chose active surveillance over surgery. Addressing women’s concerns about active surveillance may open up the possibility that if deemed [...]
The Australian National Cervical Screening Program (NCSP) introduced in 1991 has shown demonstrable success in reducing cervical cancer incidence and mortality in women aged 18 to 69 years screened with cytology every two years. Additionally, the implementation of a National Human Papillomavirus (HPV) Vaccination Program [...]
In December 2017, the Australian National Cervical Screening Program (NCSP) changed from cytology (Pap testing) to human papillomavirus (HPV) testing, increased the age of first invitation to screen, and extended the screening interval. These changes were known as the “Renewal”. When the changes were announced, [...]
Australia is one of the first high-income countries to implement primary human papillomavirus (HPV)-based screening, ahead of the USA, UK, Canada and New Zealand. Primary HPV testing has recently become one of the recommended options for cervical screening in the USA, but patients may need [...]
This study aimed to evaluate Australian web-based resources that provide information about the changes to the cervical screening program.
Profound changes were made to the Australian National Cervical Screening Program in December 2017, which included a reduction in the frequency of screening and a new cervical screening test. To explore the attitudes and experiences of health professionals practising in Australia since implementation of these [...]